(Total Views: 573)
Posted On: 06/20/2022 9:37:59 PM
Post# of 145248
Dostarlimab owned by GSK, the PD1, PD2 inhibitor
wait, that helps in both mTNBC and NASH, just like Leronlimab does, only by different MOAs.
Jemperli and Leronli
I think we are on to something
wait, that helps in both mTNBC and NASH, just like Leronlimab does, only by different MOAs.
Jemperli and Leronli
I think we are on to something
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)